Current Management of Highly Calcified Coronary Lesions: An Overview of the Current Status

Gianluca Caiazzo1, Carlo Di Mario2, Elvin Kedhi3

  • 1ICCU, San Giuseppe Moscati Hospital, ASL CE, 81031 Aversa, Italy.

PubMed

Insights

Coronary calcium amount predicts cardiac events. Intracoronary imaging helps assess calcified plaque distribution, guiding treatment for percutaneous coronary interventions (PCI) and reducing complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Coronary calcium correlates with atherosclerosis severity and future cardiac events.
  • Calcified coronary lesions pose challenges during percutaneous coronary interventions (PCI), increasing risks of complications and late stent failure.
  • Accurate plaque identification and distribution analysis are crucial for effective lesion management.

Purpose of the Study:

  • To review the assessment of calcified plaque distribution using intracoronary imaging.
  • To guide the selection of optimal devices and strategies for plaque debulking and lesion preparation in calcified lesions.

Main Methods:

  • Utilizing intracoronary imaging techniques for detailed plaque characterization.
  • Analyzing the distribution patterns of calcified plaques within the coronary vessel wall.

Main Results:

  • Intracoronary imaging provides accurate identification and spatial analysis of calcified plaques.
  • Understanding plaque distribution aids in predicting procedural risks and outcomes.
  • Tailored treatment strategies based on imaging findings can improve PCI success rates.

Conclusions:

  • Assessment of calcified plaque distribution via intracoronary imaging is essential for interventional cardiologists.
  • This assessment enables optimized selection of devices and strategies for managing complex calcified coronary lesions.
  • Improved lesion preparation strategies can mitigate PCI complications and enhance long-term stent performance.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11